George Poste sold $551K of Exelixis (EXEL)

Executed Feb 14 2025, disclosed Feb 19 2025, 5 days later.

Value, as filed

$551K

15,874 sh × $34.74

Executed

Feb 14 2025

the trade date, as filed

Disclosed

Feb 19 2025

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

GP George Poste Director profile →

George Poste (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Exelixis, Inc. (EXEL). The largest single filing was $2.7M of EXEL (60,000 sh × $45.71, as filed), executed May 7.

The name

EXEL Exelixis, Inc. EXEL · Healthcare · 53 filings in 24 months ticker →

Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→